Search Tag: Cancer
2023 19 Oct
A recent study looked at whether interventions can improve timely follow-up of overdue abnormal cancer screening results. The primary care intervention was multi-level comprising electronic health record reminders, patient outreach and navigation. Scientists evaluated this innovation through a randomised clinical trial conducted across...Read more
2023 28 Sep
In a recent report, published in the journal Cancer, researchers have documented a significant decline in cancer screenings and subsequent diagnoses in the United States during the initial stages of the Covid-19 pandemic. There were notable decreases in the number of newly diagnosed cases across six types of cancer including colorectal, female breast,...Read more
2023 19 Sep
Xencor, Inc., a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases announced the appointment of Barbara J. Klencke, M.D., to its board of directors. Dr. Klencke has more than 20 years of biopharmaceutical product development experience, and she most recently served...Read more
2023 15 Sep
Paige, a healthcare technology disrupter, has partnered with Microsoft in the battle against cancer, advancing their joint efforts to transform cancer diagnosis and patient treatment. They aim to achieve this by constructing the world's largest image-based artificial intelligence (AI) model for digital pathology and oncology. Paige has developed...Read more
2023 07 Sep
Located in Warsaw, the capital of Poland, the Maria Skłodowska-Curie National Research Institute of Oncology is a leading centre for cancer research and treatment with over 85 years of distinguished tradition. A beacon of modern oncological care, the centre comprises 13 highly specialised departments, each dedicated to providing the highest level of...Read more
2023 07 Sep
Located in Warsaw, the capital of Poland, the Maria Skłodowska-Curie National Research Institute of Oncology is a leading centre for cancer research and treatment with over 85 years of distinguished tradition. A beacon of modern oncological care, the centre comprises 13 highly specialised departments, each dedicated to providing the highest level of...Read more
2023 05 Sep
Cancer and coronary diseases, infections and new anti-bacterial active substances, digitalisation and artificial intelligence – these are some of the top issues discussed this year at the MEDICA LABMED FORUM, which is part of the MEDICA 2023 trade fair in Düsseldorf. Over the last years, the forum has developed into an especially noted part of the...Read more
2023 04 Sep
Cancer Research UK has refreshed its branding with the aim of highlighting the tangible impact of its work on the lives of cancer patients, rather than solely focusing on the science. On September 1st, Cancer Research UK launched a campaign titled 'We Are'. This campaign shines a spotlight on the moments that cancer patients and former patients...Read more
2023 30 Aug
The scale of destruction wreaked on human life and happiness by cancer hardly needs any illustration. Significant disparities exist between countries, caused primarily by differences in national wealth and income. OncoSeek provides good accuracy in detection and diagnosis and will be a game-changing and life-saving multi-cancer early detection test....Read more
2023 09 May
As a leader in women’s health, Hologic knows that increasing access to breast cancer screening is critical to detecting cancer earlier and saving lives. We commend the U.S. Preventive Services Task Force (USPSTF) for changing their draft guidelines to recommend that women begin screening at age 40. Lowering the age for initial screening to 40...Read more
2023 11 Apr
A team of researchers, from the University of Utah, have published a study in the Journal of The National Cancer Institute Cancer Spectrum to demonstrate whether a large language model (LLM) ChatGPT can deliver accurate information related to cancer information and dispel common concerns. Given the importance of accurate information in the field...Read more
2023 15 Mar
Pfizer is deploying its financial resources to accelerate the battle against cancer, having signed a $43 billion agreement to buy cancer drugmaker Seagen. Their goal is to reach deeper into new cancers treatments. Seagen specialises in a type of cancer therapy known as an antibody-drug conjugate, and its key products use lab-made proteins, known...Read more
2023 15 Mar
Pfizer is deploying its financial resources to accelerate the battle against cancer, having signed a $43 billion agreement to buy cancer drugmaker Seagen. Their goal is to reach deeper into new cancers treatments. Seagen specialises in a type of cancer therapy known as an antibody-drug conjugate, and its key products use lab-made proteins, known...Read more
2023 04 Feb
Today, February 4, is World Cancer Day. Led by The Union for International Cancer Control (UICC), the day aims to raise awareness and drive collective action in an effort to combat the disease and save lives. This is the second year of the three-year “close the care gap” campaign centred on reducing the inequities that exist in accessing quality...Read more
2022 01 Dec
Los Angeles Cancer Network (LACN), one of the leading cancer and blood disorder centers in Los Angeles , is proud to announce that board-certified hematologist/oncologist Raghu Nandan , MD and his team have officially joined it's growing network. This new addition to LACN is located at 3650 South St., Suite 212, Lakewood, CA 90712. "We...Read more
2022 18 Nov
In a cohort study of 685 adults with a positive lung cancer screening examination, adherence to recommended care improved among those with a higher suspicion of lung cancer, as well as after extending the follow-up timeline. The study was published in JAMA Network. Recruited individuals were aged 18 years and over who underwent lung cancer...Read more
2022 06 Oct
Nuvalent, Inc, a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer announced the appointment of Michael L. Meyers , M.D., Ph.D., to its Board of Directors. An experienced drug developer and medical oncologist who has contributed to the successful development and...Read more
2022 23 Sep
A research team at the University of Colorado Anschutz Medical Campus discovered a new imaging information system that could accelerate prognosis for certain cancers, including pancreatic and gastrointestinal cancers. For years the Ki67 protein has been the proliferation marker oncologists used for human tumor cells. However, medical professionals...Read more
2022 21 Jun
A team of scientists have used artificial intelligence (AI) to develop a Netflix-style algorithm to investigate and categorise DNA changes across the cancer genome. The paper, titled “Signatures of copy number alterations in human cancer”, is published in Nature. They identify 21 common faults that occur to the structure, order and number of...Read more
2022 16 Jun
Valo Therapeutics Oy, the developer of novel, adaptable immunotherapy platforms for cancer and infectious diseases announced the appointment of Dr Hemanshu Shah as Chief Business Officer (CBO), based in the US. ValoTx’s CEO, Paul Higham, said, “I am delighted to welcome Dr Hemanshu Shah as our CBO. Hemanshu brings a wealth of business development...Read more
2022 08 Jun
A small group of patients with rectal cancer have experienced a scientific miracle - a cancer drug that made their cancer vanish completely. In a small trial at Memorial Sloan Kettering Cancer Center, patients with rectal cancer received dostarlimab, an anti–PD-1 monoclonal antibody, administered every three weeks for six months. The trial included...Read more
2022 20 May
The ComedyCures Foundation collaborated with the mental health platform, Neolth, to determine if using comedy in a self-care app can improve mental health in patients with advanced cancer. Participants (31 women) used the Neolth app for eight weeks from September 2021 to November 2021, watching at least one ComedyCures video and practicing...Read more
2022 16 May
Arcellx, Inc.a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases announced the appointment of Olivia Ware to its Board of Directors. Ms. Ware, a successful executive, brings a wealth of knowledge from her more than 20 years of experience in biotech...Read more
2022 09 May
GE Healthcare is proud to announce that it has entered into an agreement to collaborate with RaySearch Laboratories AB (publ), a leading radiation oncology software provider, to develop a new radiation therapy simulation and treatment planning workflow solution, designed to simplify how radiation will be targeted to shrink a tumor. The companies...Read more
2022 17 Feb
Dr. Marleau will direct the Company’s R&D efforts and advance its pipeline of subtractive therapies treating cancer and other terminal diseases Immunicom, Inc., a clinical-stage biotechnology company pioneering subtractive therapies to treat unmet medical needs in cancer and other terminal diseases, announced that Dr. Annette Marleau is assuming...Read more
2022 15 Feb
Pharma Industry Veteran Brings Critical Expertise in Real-World Evidence Generation and Data Analytics Strategies to the Company Carevive Systems the leading oncology-focused health technology company centered on understanding and improving the experience of patients with cancer has announced that it has appointed Aaron Galaznik, M.D. as...Read more